+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Angiotensin Type 1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Type 1 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin 6 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 6 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HAVCR2 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HAVCR2 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Immunoglobulin Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Immunoglobulin Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Amyloid Precursor Protein Secretase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Amyloid Precursor Protein Secretase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Iron Deficiency Anemia - Pipeline Insight, 2025 - Product Thumbnail Image

Iron Deficiency Anemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Nerve Growth Factor Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Nerve Growth Factor Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Tau Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Tau Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Sodium-glucose Transporter 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Sodium-glucose Transporter 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Factor Xa Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Factor Xa Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HIV Integrase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HIV Integrase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Graves' Ophthalmopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Ophthalmopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Ventricular Tachycardia (V-tach Or VT) - Pipeline Insight, 2025 - Product Thumbnail Image

Ventricular Tachycardia (V-tach Or VT) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Dup15q Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Dup15q Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
E-Selectin Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

E-Selectin Inhibitor- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
NF-kappa B Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

NF-kappa B Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
D Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

D Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Chemokine Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Chemokine Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more